BMO upgrades Ionis Pharmaceuticals stock rating on sHTG opportunity
In
Investing.comBy Investing.com10/21/2026, 8:52:48 PM
EXECUTIVE SUMMARY
BMO upgrades Ionis Pharmaceuticals stock rating on sHTG opportunity....
Key Takeaways
- BMO upgrades Ionis Pharmaceuticals stock rating on sHTG opportunity.
Read Complete Original Article
Published originally on Investing.com
Related News
finance6 minutes ago
Earnings call transcript: CSX tops Q3 2026 estimates as shares jump 4% - Investing.com Australia
Earnings call transcript: CSX tops Q3 2026 estimates as shares jump 4% Investing.com Australia
finance8 minutes ago
EverQuote stock rises on $50M share buyback program
EverQuote stock rises on $50M share buyback program....
finance10 minutes ago
Meta Q3 2026 slides: revenue surges 26% as margins compress sharply
Meta Q3 2026 slides: revenue surges 26% as margins compress sharply....
finance12 minutes ago
Las Vegas Sands Q3 2026 slides: EBITDA falls 17% amid premium weakness
Las Vegas Sands Q3 2026 slides: EBITDA falls 17% amid premium weakness....
Multikhabar App
All Information In One Place
Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!